PCDHGB7 CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. PCDHGB7 Gen Silencer sind erhältlich als PCDHGB7 CRISPR/Cas9 Knockout Plasmide und PCDHGB7 Double Nickase Plasmide. PCDHGB7 CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
PCDHGB7 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PCDHGB7 CRISPR/Cas9 KO Plasmid (h) | sc-410039 | h | Gene Knockout | GFP | 0 | ||
PCDHGB7 HDR Plasmid (h) | sc-410039-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PCDHGB7 Double Nickase Plasmid (h) | sc-410039-NIC | h | Gene Knockout | Puromycin | 0 | ||
PCDHGB7 Double Nickase Plasmid (h2) | sc-410039-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Pcdhgb7 CRISPR/Cas9 KO Plasmid (m) | sc-430013 | m | Gene Knockout | GFP | 0 | ||
Pcdhgb7 HDR Plasmid (m) | sc-430013-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Pcdhgb7 Double Nickase Plasmid (m) | sc-430013-NIC | m | Gene Knockout | Puromycin | 0 | ||
Pcdhgb7 Double Nickase Plasmid (m2) | sc-430013-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Pcdhgb8 CRISPR/Cas9 KO Plasmid (m) | sc-430014 | m | Gene Knockout | GFP | 0 | ||
Pcdhgb8 HDR Plasmid (m) | sc-430014-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Pcdhgb8 Double Nickase Plasmid (m) | sc-430014-NIC | m | Gene Knockout | Puromycin | 0 | ||
Pcdhgb8 Double Nickase Plasmid (m2) | sc-430014-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PCDHGB7 CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PCDHGB7 CRISPR Activation Plasmid (h) | sc-410039-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGB7 CRISPR Activation Plasmid (h2) | sc-410039-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGB7 Lentiviral Activation Particles (h) | sc-410039-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGB7 Lentiviral Activation Particles (h2) | sc-410039-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb7 CRISPR Activation Plasmid (m) | sc-430013-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb7 CRISPR Activation Plasmid (m2) | sc-430013-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb7 Lentiviral Activation Particles (m) | sc-430013-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb7 Lentiviral Activation Particles (m2) | sc-430013-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb8 CRISPR Activation Plasmid (m) | sc-430014-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb8 CRISPR Activation Plasmid (m2) | sc-430014-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb8 Lentiviral Activation Particles (m) | sc-430014-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb8 Lentiviral Activation Particles (m2) | sc-430014-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |